Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin type-A receptor 1 (EPHA1) is a receptor tyrosine kinase that binds to membrane-bound ephrin-A ligands on adjacent cells, mediating contact-dependent bidirectional signaling. It plays roles in cell proliferation, angiogenesis, apoptosis, cell adhesion, cell migration, tissue boundary formation, axon guidance, and long-term potentiation. EPHA1 is implicated in carcinogenesis and may act as a tumor suppressor. Its expression pattern makes it relevant for biomarker research related to inflammation or cancer progression.
Activation by ephrin-A ligands induces cell attachment to the extracellular matrix while inhibiting cell spreading and motility via regulation of ILK, RHOA, and RAC pathways. Initiates forward signaling cascades and induces reverse signaling, regulating cytoskeletal dynamics via small GTPases such as RHOA/RAC.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin type-A receptor 1 (EPHA1).